Products for Research Use Only
RegisterLogin

Anbenitamab

CAT: 0804-HY-P99437-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99437-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Anbenitamab (KN-026) is a bispecific antibody simultaneously targeting extracellular domains II and IV of human HER2. Anbenitamab blocks both ligand-dependent and ligand-independent HER2 signaling pathways. Anbenitamab mediates antibody-dependent cellular cytotoxicity (ADCC) via FcγIIIa binding. Ambrinitumab can be used in research for lung cancer, HER2-positive metastatic breast cancer (MBC), gastric cancer, and gastroesophageal junction cancer[1][2][3][4].
CAS Number
2367012-88-0
Product Name Alternative
KN-026
UNSPSC
12352203
Target
EGFR
Type
Inhibitory Antibodies
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anbenitamab.html
Purity
99.22
Solubility
H2O
Smiles
[Anbenitamab]
Molecular Weight
(145.16 kDa)
References & Citations
[1]Dongmei Ji, et al. Abstract 3022: Using translational tumor growth inhibition modeling approach and population PK analysis to predict efficacious doses for KN026, a HER2 bispecific antibody. Cancer Res (2020) 80 (16_Supplement) : 3022.|[2]Jian Zhang, et al. First-in-human HER2-targeted Bispecific Antibody KN026 for the Treatment of Patients with HER2-positive Metastatic Breast Cancer: Results from a Phase I Study. Clin Cancer Res. 2022 Feb 15;28 (4) :618-628.|[3]Wang Z, et al. Anti-HER2 biparatopic antibody KJ015 has near-native structure, functional balanced high affinity, and synergistic efficacy with anti-PD-1 treatment in vivo. MAbs. 2024 Jan-Dec;16 (1) :2412881.|[4]Xu J, et al. KN026 (anti-HER2 bispecific antibody) in patients with previously treated, advanced HER2-expressing gastric or gastroesophageal junction cancer. Eur J Cancer. 2023 Jan;178:1-12.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Isoform
ErbB2/HER2

Alternative Products

CatalogName
MBS5818830Anbenitamab
GTR18337867-01Anbenitamab Antibody
MBS1563383-01Research Grade Anbenitamab
E55B1143Anbenitamab (Reference antibody)
ICH5344-5mgAnbenitamab Biosimilar - Research Grade
GTR18697399-01Anbenitamab Human Monoclonal Antibody
21-886Anbenitamab - Research Grade Biosimilar
048124ERBB2/HER2/CD340 (Anbenitamab) discontinued
GTR18316201ERBB2 / HER2 / CD340 Reference Antibody (Anbenitamab)
F1434-5Anti-ERBB2/HER2/CD340 Antibody (Anbenitamab)

Popular Products